Pharmacyte BiotechPMCB
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 28 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, down 4 from Q1 2026. 2 opened new positions and 5 sold out. The largest holders were Citadel Advisors ($218K), Geode Capital Management, LLC ($96K) and Vanguard Capital Management LLC ($44K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $35K |
| Exits | 5 | $57K |
All 13F filers, Q1 2026 → Q2 2026: 78,837 shares bought and 283,647 shares sold, net −204,810 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Citadel Advisors | 0.00% | Reduce -21.2% | 283,381 | $218K |
| Geode Capital Management, LLC | 0.00% | Reduce -36.5% | 124,247 | $96K |
| Vanguard Capital Management LLC | 0.00% | Add +10.3% | 56,778 | $44K |
| Susquehanna International Group, LLP | 0.00% | New | 44,853 | $35K |
| Renaissance Technologies | 0.00% | Reduce -32.8% | 37,987 | $29K |
| XTX Topco Ltd | 0.00% | Reduce -34.7% | 34,180 | $26K |
| Northern Trust Corp. | 0.00% | Reduce -8.4% | 32,624 | $25K |
| Jane Street Group, LLC | 0.00% | Add +160.8% | 30,064 | $23K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -0.3% | 26,926 | $21K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 23,452 | $18K |
| Equitec Proprietary Markets, LLC | 0.00% | No change | 22,227 | $17K |
| Commonwealth Equity Services, LLC | 0.00% | Add +96.4% | 20,255 | $16K |
| HRT Financial LP | 0.00% | Reduce -37.5% | 15,451 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.0% | 4,888 | $4K |
| UBS Group AG | 0.00% | Reduce -8.3% | 4,142 | $3K |
| Group One Trading LLC | 0.00% | Reduce -72.0% | 500 | $385 |
| Osaic Holdings, Inc. | 0.00% | Add +0.3% | 303 | $232 |
| Barclays PLC | 0.00% | New | 192 | $148 |
| Sachetta, LLC | 0.00% | No change | 14 | $11 |
| SBI Securities Co., Ltd. | 0.00% | Add +100.0% | 6 | $5 |
| Bfsg, LLC | 0.00% | No change | 5 | $4 |
| Morgan Stanley | 0.00% | Add +100.0% | 2 | $2 |
| Financial Consulate, Inc. | 0.00% | No change | 2 | $2 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $2 |
| Johnson Financial Group, Inc. | 0.00% | No change | 1 | $1 |
| MCF Advisors LLC | 0.00% | No change | 1 | $1 |
| BlackRock, Inc. | 0.00% | No change | 1 | $1 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.